J G Chung Selected Research

Neoplasms (Cancer)

5/2005	Berberine inhibits arylamine N-acetyltransferase activity and gene expression in mouse leukemia L 1210 cells.
12/2004	Differential effects of allyl sulfides from garlic essential oil on cell cycle regulation in human liver tumor cells.
10/2004	Diallyl disulfide (DADS) induced apoptosis undergo caspase-3 activity in human bladder cancer T24 cells.
2/2004	Inhibition of N-acetyltransferase activity and gene expression in human colon cancer cell lines by diallyl sulfide.
6/2003	Curcumin inhibited the arylamines N-acetyltransferase activity, gene expression and DNA adduct formation in human lung cancer cells (A549).
9/2002	Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforms (GBM 8401) cells.
5/2002	The effect of paclitaxel on 2-aminofluorene-DNA adducts formation and arylamine N-acetyltransferase activity and gene expression in human lung tumor cells (A549).
12/2001	Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display.
12/2001	Ellagic [correction of ellagica] acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301).
3/2001	Effects of the butylated hydroxyanisole and butylated hydroxytoluene on the DNA adduct formation and arylamines N-acetyltransferase activity in human colon tumor cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J G Chung Research Topics

Disease

15	Neoplasms (Cancer) 05/2005 - 05/2000
9	Leukemia 05/2005 - 01/2000
5	Urinary Bladder Neoplasms (Bladder Cancer) 10/2004 - 08/2000
2	Leukemia L1210 05/2005 - 07/2001
2	Hepatocellular Carcinoma (Hepatoma) 06/2003 - 01/2001
1	Peptic Ulcer (Peptic Ulcers) 01/2011
1	Hemorrhage 01/2011
1	Colonic Neoplasms (Colon Cancer) 02/2004
1	Lung Neoplasms (Lung Cancer) 06/2003
1	Prostatitis 01/2003
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2002
1	Brain Neoplasms (Brain Tumor) 09/2002
1	Astrocytoma (Pilocytic Astrocytoma) 09/2002
1	Glioblastoma (Glioblastoma Multiforme) 09/2002
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2001
1	Carcinogenesis 12/2001
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2001
1	Ulcer 06/2001
1	Glioma (Gliomas) 03/2001
1	Stomach Neoplasms (Stomach Cancer) 01/2001
1	Anaphylaxis (Anaphylactic Shock) 05/2000
1	Adenocarcinoma 02/2000

Drug/Important Bio-Agent (IBA)

20	N-acetyltalosaminuronic acid (NAT)IBA 05/2005 - 01/2000
17	Arylamine N-AcetyltransferaseIBA 05/2005 - 01/2000
10	AcetyltransferasesIBA 02/2004 - 01/2000
10	DNA AdductsIBA 06/2003 - 01/2000
8	2-aminofluoreneIBA 02/2004 - 01/2000
7	Messenger RNA (mRNA)IBA 05/2005 - 01/2001
6	DNA (Deoxyribonucleic Acid)IBA 06/2003 - 01/2000
4	Proteins (Proteins, Gene)FDA Link 05/2005 - 10/2001
3	BerberineIBA 05/2005 - 01/2000
3	allyl sulfideIBA 12/2004 - 01/2002
3	amsonic acid (DAS)IBA 12/2004 - 01/2002
3	diallyl disulfide (diallyl disulphide)IBA 12/2004 - 01/2002
3	Caspase 3 (Caspase-3)IBA 10/2004 - 01/2004
3	2-aminofluorene-DNA complexIBA 01/2002 - 01/2000
3	4-Aminobenzoic Acid (4 Aminobenzoic Acid)IBA 10/2001 - 05/2000
2	EnzymesIBA 02/2004 - 01/2001
2	NucleotidesIBA 06/2003 - 03/2001
2	CarcinogensIBA 05/2002 - 12/2001
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2002 - 05/2002
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2001 - 08/2000
2	LuteolinIBA 07/2001 - 06/2001
2	Butylated Hydroxytoluene (BHT)IBA 03/2001 - 11/2000
2	Butylated Hydroxyanisole (BHA)IBA 03/2001 - 11/2000
1	Sulfides (Thioethers)IBA 12/2004
1	Volatile Oils (Essential Oils)IBA 12/2004
1	diallyl trisulfideIBA 12/2004
1	aloe emodinIBA 08/2004
1	CaspasesIBA 01/2004
1	baicaleinIBA 01/2004
1	CurcuminIBA 06/2003
1	5-MethoxypsoralenIBA 06/2003
1	GlucuronidesIBA 10/2002
1	QuercetinIBA 10/2002
1	Complementary DNA (cDNA)IBA 12/2001
1	GTP Phosphohydrolases (GTPases)IBA 12/2001
1	A-Form DNA (A-DNA)IBA 12/2001
1	SuspensionsIBA 12/2001
1	AcidsIBA 12/2001
1	Ellagic AcidIBA 12/2001
1	Sulindac (Copal)FDA LinkGeneric 12/2001
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 10/2001
1	Carmustine (FIVB)FDA Link 03/2001
1	Menthol FDA Link 01/2001
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2001
1	Tamoxifen FDA LinkGeneric 01/2001
1	Cantharidin (Cantharides)IBA 01/2001
1	Biological ProductsIBA 01/2001
1	norcantharidinIBA 01/2001
1	Immunoglobulin E (IgE)IBA 05/2000
1	p-Methoxy-N-methylphenethylamineIBA 05/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2000
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 02/2000
1	Antineoplastic Agents (Antineoplastics)IBA 01/2000

Therapy/Procedure

1	Endoscopic Hemostasis 01/2011
1	Aftercare (After-Treatment) 01/2003